Literature DB >> 10626924

Depressive disorders in Chinese patients with Alzheimer's disease.

C Y Liu1, J L Fuh, E L Teng, S J Wang, P N Wang, Y Y Yang, H C Liu.   

Abstract

OBJECTIVE: The present study was to investigate the prevalence and potential risk factors of depressive disorders in Chinese patients with Alzheimer's disease (AD).
METHOD: A series of consecutive AD patients from the Memory Disorders Clinic of the Veterans General Hospital, Taipei were studied. Psychiatric diagnosis was made according to DSM-III-R criteria with the use of the Structured Clinical Interview for DSM-III-R (SCID). The Chinese version of the Cognitive Abilities Screening Instrument (CASI) and the Hamilton Depression Rating Scale (HDRS) were also applied. Primary caregivers were interviewed for the Clinical Dementia Rating (CDR) scale, the Barthel Index and the Alzheimer's Deficit Scale (ADS).
RESULTS: Among 141 AD patients, seven (5.0%) were diagnosed with major depression, 11 (7.8%) with dysthymia and five (3.5%) with depressive disorder not otherwise specified. Women were at elevated risk for depressive disorders and had more severe symptoms of depression.
CONCLUSIONS: The prevalence of depressive disorders among Chinese AD patients is in the middle of the range of western findings. The risk factor for depression is female gender.

Entities:  

Mesh:

Year:  1999        PMID: 10626924     DOI: 10.1111/j.1600-0447.1999.tb10896.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

2.  Incidence and Course of Depression in Patients with Alzheimer's Disease.

Authors:  Seung-Ho Ryu; Han-Yong Jung; Kang Joon Lee; Seok Woo Moon; Dong Woo Lee; Narei Hong; Baik Seok Kee; Do Hoon Kim; Changsu Han; Chang Uk Lee
Journal:  Psychiatry Investig       Date:  2017-05-16       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.